Adam, originally from Hertfordshire, completed his MChem in 2022 at the University of Oxford. His Part II (master’s) project was on the design and synthesis of aryl hydrocarbon receptor degraders as utrophin modulators for Duchenne muscular dystrophy, supervised by Professor Angela Russell. In August 2022 Adam joined the Ciulli group at the Centre for Targeted Protein Degradation as an Associate Scientist in Medicinal and Organic Chemistry, within the Boehringer Ingelheim collaboration team. He remains at the CeTPD for his PhD, developing electrophilic kinase-targeted molecular glues in the Farnaby group. Outside of the lab, Adam enjoys travelling, watching the F1 and live music.